| 1. | | Recruiting | Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer
Conditions: Breast Cancer; nausea and vomiting |
| 2. | | Recruiting | Allo Transplantation with Mylotarg, fludarabine and melphalan for AML, CML and MDS.
Conditions: Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Chronic Lymphocytic Leukemia |
| 3. | | Recruiting | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
Conditions: adult solid tumor; Breast Cancer; Lung Cancer; neurotoxicity; ovarian epithelial cancer; Prostate Cancer |
| 4. | | Recruiting | Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction
Conditions: Adenocarcinoma of the Esophagus; stage III esophageal cancer; stage IV esophageal cancer |
| 5. | | Recruiting | Avastin Plus Rituximab for Patients with Relapsed and Chemotherapy - or Rituxan-Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma, B-Cell |
| 6. | | Recruiting | Bevacizumab and PEG-Interferon alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
Conditions: recurrent gastrointestinal carcinoid tumor; metastatic gastrointestinal carcinoid tumor; regional gastrointestinal carcinoid tumor |
| 7. | | Recruiting | Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
Conditions: blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia |
| 8. | | Recruiting | Bortezomib and Mitoxantrone in Treating Patients With Advanced or Metastatic Androgen-Independent Prostate Cancer
Conditions: recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer |
| 9. | | Recruiting | Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
Conditions: relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ... |
| 10. | | Recruiting | Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
Conditions: Leukemia, Lymphocytic, Chronic; Leukemia, Lymphocytic, Acute; Lymphoma, Low-Grade; Lymphoma, T-Cell; Lymphoma, B-Cell |
| 11. | | Recruiting | Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
Condition: Chronic Lymphocytic Leukemia |
| 12. | | Recruiting | Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Conditions: stage II anal cancer; stage IIIA anal cancer; stage IIIB anal cancer; squamous cell carcinoma of the anus |
| 13. | | Recruiting | CC-5013 in Myelofibrosis
Condition: Myelofibrosis |
| 14. | | Recruiting | CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer; ... |
| 15. | | Recruiting | CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 16. | | Recruiting | CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; recurrent adult diffuse large cell lymphoma; recurrent adult Hodgkin's lymphoma |
| 17. | | Not yet recruiting | Celecoxib and/or EKB-569 in Preventing Oral Cancer in Patients With Oral Leukoplakia
Conditions: lip and oral cavity cancer; Salivary Gland Cancer; Precancerous Condition |
| 18. | | Recruiting | Celecoxib in Treating Patients With Bladder Cancer
Condition: recurrent bladder cancer |
| 19. | | Recruiting | Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis.
Conditions: Colon Cancer; Rectal Cancer |
| 20. | | Recruiting | Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer |
| 21. | | Recruiting | Chemotherapy, Interferon alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
Conditions: stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas |
| 22. | | Recruiting | Cilengitide in Treating Patients With Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 23. | | Recruiting | Cilengitide in Treating Patients With Metastatic Melanoma
Condition: Stage IV Melanoma |
| 24. | | Recruiting | Clofarabine alone versus Clofarabine in Combination with Low-Dose Cytarabine (ara-C) in Previously Untreated Patients with Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome |
| 25. | | Recruiting | Clofarabine combinations in relapsed/refractory AML, MDS and myeloid blast phase CML
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia |
| 26. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
Conditions: Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
| 27. | | Recruiting | Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets
Conditions: Leukemia; Lymphoma |
| 28. | | Recruiting | Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
Conditions: Colorectal Cancer; stage I colon cancer; stage II colon cancer; stage III colon cancer; stage IV colon cancer |
| 29. | | Recruiting | Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 30. | | Recruiting | Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
Conditions: recurrent thyroid cancer; stage IV follicular thyroid cancer; stage IV papillary thyroid cancer |
| 31. | | Recruiting | Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008
Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases |
| 32. | | Recruiting | Docetaxel in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 33. | | Recruiting | Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases
Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases |
| 34. | | Recruiting | Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases
Conditions: recurrent prostate cancer; stage IV prostate cancer; bone metastases |
| 35. | | Recruiting | Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer |
| 36. | | Recruiting | Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction
Conditions: recurrent adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ... |
| 37. | | Recruiting | Evaluation of Differing Taxanes/Taxane Combinations on the Outcomes of Patients with Operable Breast Cancer
Condition: Breast Cancer |
| 38. | | Recruiting | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
Condition: Breast Cancer |
| 39. | | Recruiting | Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears
Condition: Cervical Cancer |
| 40. | | Recruiting | Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
Conditions: Bladder Cancer; Urethral Cancer |
| 41. | | Recruiting | Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
Conditions: recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 42. | | Recruiting | Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
Conditions: lip and oral cavity cancer; Oropharyngeal Cancer; stage 0 lip and oral cavity cancer; stage 0 oropharyngeal cancer |
| 43. | | Recruiting | Hepatic Artery Infusion of CD34+ Cells
Conditions: Stem Cell Transplantation; Liver Diseases |
| 44. | | Recruiting | Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Conditions: relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ... |
| 45. | | Recruiting | Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Conditions: recurrent prostate cancer; stage IV prostate cancer; bone metastases |
| 46. | | Recruiting | Hormone Therapy in Preventing Endometrial Carcinogenesis (Cancer) in Women With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Conditions: Endometrial Cancer; hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2) |
| 47. | | Recruiting | Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
Conditions: accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ... |
| 48. | | Recruiting | Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer
Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer |
| 49. | | Recruiting | An Immunotherapy Vaccine Against Grade IV Brain Tumors
Condition: Brain Neoplasms |
| 50. | | Recruiting | Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
